The NapaJen team is building a Pipeline of therapeutics addressing significant market needs through augmentation of immuno-oncology treatments as well as organ and stem cell transplantation opportunities.
By loading different oligo drugs onto its drug delivery platform, NapaJen has made both "precision-targeted immunosuppressive" treatment as well as "controlled immuno-stimulation" possible in preclinical models.